NL940017I1 - Vaccin-preparaat - Google Patents

Vaccin-preparaat

Info

Publication number: NL940017I1
Authority: NL; Netherlands
Prior art keywords: canine coronavirus; vaccine preparation; attenuated; intestines; dogs
Prior art date: 1983-06-15

Application number

NL940017C

Other languages

English (en)

Other versions

NL940017I2 (nl

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-06-15

Filing date

1994-08-18

Publication date

1994-10-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27054825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL940017(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1983-06-15 Priority claimed from US06/504,434 external-priority patent/US4567043A/en

1994-08-18 Application filed by American Home Prod filed Critical American Home Prod

1994-10-17 Publication of NL940017I1 publication Critical patent/NL940017I1/nl

2001-02-01 Publication of NL940017I2 publication Critical patent/NL940017I2/nl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

NL940017C 1983-06-15 1994-08-18 Vaccin-preparaat. NL940017I2 (nl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US06/504,434 US4567043A (en)	1983-06-15	1983-06-15	Canine corona virus vaccine
US06/618,638 US4567042A (en)	1983-06-15	1984-06-07	Inactivated canine coronavirus vaccine
EP84902632A EP0145783B2 (en)	1983-06-15	1984-06-14	Canine coronavirus vaccine

Publications (2)

Publication Number	Publication Date
NL940017I1 true NL940017I1 (nl)	1994-10-17
NL940017I2 NL940017I2 (nl)	2001-02-01

Family

ID=27054825

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL940017C NL940017I2 (nl)	1983-06-15	1994-08-18	Vaccin-preparaat.

Country Status (7)

Country	Link
US (1)	US4567042A (nl)
EP (4)	EP0344872B2 (nl)
AT (4)	ATE50913T1 (nl)
DE (4)	DE3486495D1 (nl)
ES (1)	ES8604422A1 (nl)
NL (1)	NL940017I2 (nl)
WO (1)	WO1985000014A1 (nl)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4990367A (en) *	1987-03-09	1991-02-05	Diamond Scientific Company	Canine distemper virus vaccine
US5565209A (en) *	1987-03-17	1996-10-15	Akzo Nobel N.V.	Adjuvant mixture
EP0283085B1 (en) *	1987-03-17	1992-11-11	Akzo N.V.	Adjuvant mixture
US4904468A (en) *	1987-06-08	1990-02-27	Norden Laboratories, Inc.	Canine coronavirus vaccine
US5911999A (en) *	1987-09-28	1999-06-15	Pfizer, Inc.	Vaccine based on TGEV for protection of dogs against canine coronavirus
ZA903142B (en) *	1989-05-03	1991-02-27	Akzo Nv	Canine corona virus vaccine
US5672350A (en) *	1989-08-22	1997-09-30	Veterinary Infectious Disease Organization	Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
US6004563A (en) *	1990-11-07	1999-12-21	American Home Products Corporation	Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US6372224B1 (en)	1990-11-14	2002-04-16	Pfizer Inc.	Canine coronavirus S gene and uses therefor
US6057436A (en) *	1990-11-14	2000-05-02	Pfizer Inc.	Canine coronavirus S gene and uses therefor
ATE256746T1 (de) *	1991-04-25	2004-01-15	Akzo Nobel Nv	Subeinheits-impfstoff gegen hundecoronavirus
US5750112A (en) *	1993-02-26	1998-05-12	Solvay Animal Health, Inc.	Canine coronavirus vaccine from feline enteric coronavirus
US20040048235A1 (en) *	1995-08-29	2004-03-11	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US20040053208A1 (en) *	1995-08-29	2004-03-18	V. I. TECHNOLOGIES, Inc.	Methods to selectively inactivate parasites in biological compositions
GB9622159D0 (en) *	1996-10-24	1996-12-18	Solvay Sociutu Anonyme	Polyanionic polymers as adjuvants for mucosal immunization
US6093564A (en)	1997-10-03	2000-07-25	V.I. Technologies, Inc.	Methods and compositions for the selective modification of nucleic acids
US6369048B1 (en)	1998-01-12	2002-04-09	V.I. Technologies, Inc.	Methods and compositions for inactivating viruses
FR2775601B1 (fr)	1998-03-03	2001-09-21	Merial Sas	Vaccins vivants recombines et adjuves
US6617100B2 (en)	1998-09-25	2003-09-09	V.I. Technologies, Inc.	Solid phase quenching systems
US6150109A (en)	1999-01-25	2000-11-21	V. I. TECHNOLOGIES, Inc.	Lipophilic quenching of viral inactivating agents
US20020131958A1 (en) *	2001-01-22	2002-09-19	John Chapman	Method for purifying a biological composition
US20030129161A1 (en) *	2001-09-17	2003-07-10	Hsien-Jue Chu	Interleukin-12 as a veterinary vaccine adjuvant
CA2510189A1 (en) *	2002-12-19	2004-07-08	Thomas Gore	Trivalent vaccine with maternal antibody transfer via the milk
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
ES2303046T3 (es) *	2003-01-29	2008-08-01	Pfizer Products Inc.	Vacunas caninas contra bordetella bronchiseptica.
GB0315323D0 (en) *	2003-07-01	2003-08-06	Royal Veterinary College	Vaccine composition
US9023366B2 (en)	2003-07-01	2015-05-05	The Royal Veterinary College	Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
WO2005040359A1 (en) *	2003-10-23	2005-05-06	Pfizer Products Inc.	Vaccine for periodontal disease
WO2006106424A2 (en) *	2005-04-07	2006-10-12	Pharmacia & Upjohn Company Llc	Formulations and process for production of bordetella bronchiseptica p68 antigen and vaccines
PT1780216E (pt) *	2005-10-26	2011-02-03	Canio Buonavoglia	Coronavírus canino pantrópico
US7682619B2 (en) *	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
KR101013226B1 (ko) *	2008-05-14	2011-02-10	녹십자수의약품(주)	개 바이러스성 설사병 예방용 백신
US20110110980A1 (en)	2009-09-02	2011-05-12	Wyeth Llc	Heterlogous prime-boost immunization regimen
UY34745A (es)	2012-04-18	2013-11-29	Zoetis Llc	Vacunas y procedimientos para tratar la enfermedad de lyme en perros
US20140170180A1 (en)	2012-12-17	2014-06-19	Boehringer Ingelheim Vetmedica, Inc.	Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en)	2013-02-15	2014-08-21	Boehringer Ingelheim Vetmedica, Inc.	Porcine parvovirus 5b, methods of use and vaccine
CN105073130A (zh)	2013-03-15	2015-11-18	勃林格殷格翰动物保健公司	猪生殖与呼吸综合征病毒、组合物、疫苗及使用方法
WO2019092027A1 (en)	2017-11-09	2019-05-16	Boehringer Ingelheim Vetmedica Gmbh	Sapelovirus immunogenic compositions and uses thereof
BR112021013241A2 (pt)	2019-01-04	2021-09-14	Boehringer Ingelheim Animal Health USA Inc.	Cepas atenuadas de bordetella bronchiseptica, vacinas orais contendo as cepas atenuadas e métodos de preparação e uso das mesmas
CN109765384B (zh) *	2019-01-29	2022-11-18	北京勤邦生物技术有限公司	一种犬冠状病毒抗体荧光检测试纸条及其制备方法和应用
CN112402599B (zh) *	2019-08-23	2023-06-27	中国农业科学院特产研究所	一种犬用犬瘟热、细小病毒病二联灭活疫苗及其制备方法
WO2022149342A1 (ja) *	2021-01-06	2022-07-14	パナソニックホールディングス株式会社	排泄物判定方法、排泄物判定装置、及び排泄物判定プログラム

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3143474A (en) *	1962-07-30	1964-08-04	Sterling Drug Inc	Preparation of duck-embryo modified infectious canine hepatitis virus vaccine
US3704203A (en) †	1967-08-24	1972-11-28	Diamond Lab Inc	Transmissible gastroenteritis vaccines and methods of producing the same
US3652761A (en) *	1969-09-04	1972-03-28	Corning Glass Works	Immunochemical composites and antigen or antibody purification therewith
US3959251A (en) *	1970-06-25	1976-05-25	Exploaterings Aktiebolaget T.B.F.	Stabilized agar product and method for its stabilization

1984
- 1984-06-07 US US06/618,638 patent/US4567042A/en not_active Expired - Lifetime
- 1984-06-14 DE DE3486495T patent/DE3486495D1/de not_active Expired - Lifetime
- 1984-06-14 DE DE3486292T patent/DE3486292T2/de not_active Expired - Lifetime
- 1984-06-14 AT AT84902632T patent/ATE50913T1/de not_active IP Right Cessation
- 1984-06-14 DE DE3486293T patent/DE3486293T3/de not_active Expired - Lifetime
- 1984-06-14 DE DE8484902632T patent/DE3481582D1/de not_active Expired - Lifetime
- 1984-06-14 WO PCT/US1984/000904 patent/WO1985000014A1/en active IP Right Grant
- 1984-06-14 AT AT89201996T patent/ATE280217T1/de not_active IP Right Cessation
- 1984-06-14 EP EP89202001A patent/EP0344872B2/en not_active Expired - Lifetime
- 1984-06-14 EP EP19890201996 patent/EP0345911B1/en not_active Expired - Lifetime
- 1984-06-14 EP EP19890201017 patent/EP0329264B1/en not_active Expired - Lifetime
- 1984-06-14 EP EP84902632A patent/EP0145783B2/en not_active Expired - Lifetime
- 1984-12-14 ES ES538588A patent/ES8604422A1/es not_active Expired
1989
- 1989-04-20 AT AT89201017T patent/ATE103181T1/de not_active IP Right Cessation
- 1989-07-31 AT AT89202001T patent/ATE103180T1/de not_active IP Right Cessation
1994
- 1994-08-18 NL NL940017C patent/NL940017I2/nl unknown

Also Published As

Publication number	Publication date
DE3486293T2 (de)	1994-06-30
DE3486292D1 (de)	1994-04-28
EP0344872A1 (en)	1989-12-06
EP0344872B2 (en)	2002-04-24
NL940017I2 (nl)	2001-02-01
EP0145783A4 (en)	1985-10-14
DE3486293T3 (de)	2002-11-21
DE3481582D1 (de)	1990-04-19
ES8604422A1 (es)	1986-02-01
ATE50913T1 (de)	1990-03-15
EP0344872B1 (en)	1994-03-23
WO1985000014A1 (en)	1985-01-03
EP0145783B1 (en)	1990-03-14
DE3486495D1 (de)	2004-11-25
DE3486292T2 (de)	1994-06-30
EP0145783B2 (en)	2004-01-02
EP0329264B1 (en)	1994-03-23
ES538588A0 (es)	1986-02-01
ATE280217T1 (de)	2004-11-15
EP0329264A2 (en)	1989-08-23
EP0345911A1 (en)	1989-12-13
US4567042A (en)	1986-01-28
ATE103181T1 (de)	1994-04-15
DE3486293T4 (de)	1995-06-14
EP0145783A1 (en)	1985-06-26
DE3486293D1 (de)	1994-04-28
EP0345911B1 (en)	2004-10-20
ATE103180T1 (de)	1994-04-15
EP0329264A3 (en)	1989-12-13

Publication	Publication Date	Title
ATE103180T1 (de)	1994-04-15	Impfstoff-zubereitung.
DK94884D0 (da)	1984-02-23	Selvluftende, ikke-udkernende kanylesamling
ATE82509T1 (de)	1992-12-15	Orale impfstoffe.
DE3882599D1 (de)	1993-09-02	Hundecoronavirus-impfstoff.
IE802141L (en)	1981-04-16	Vaccine
SE7512828L (sv)	1976-05-24	Calicivirusvaccin
BE888487A (fr)	1981-08-17	Vaccin anti-parvovirus canin et procede de preparation,
KR830005871A (ko)	1983-09-14	광견병 백신의 제조방법
ES522057A0 (es)	1985-08-16	Procedimiento de preparar derivados cicloalcaenicos, particularmente utiles en la cria de animales.
DE68918649D1 (de)	1994-11-10	Lebende Newcastle-Krankheit-Virus-Vakzine.
SE7700652L (sv)	1977-07-24	Forfarande for framstellning av ett vaccin mot panleukopeni hos katt
ES2020562B3 (es)	1991-08-16	Metodo para regular la reproduccion animal.
ATE66818T1 (de)	1991-09-15	Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis.
ES460321A1 (es)	1978-11-01	Metodo para la preparacion de mutante viral no virulento, del virus aujeszky.
DK233188D0 (da)	1988-04-28	Pyrrolophenylalkanolaminer, fremgangsmaader til deres fremstilling samt deres anvendelse som ydelsesfremmende midler til dyr
KR830003909A (ko)	1983-06-30	백신의 제조방법
KR880015574U (ko)	1988-10-06	농작물 유해 조수 퇴치용 모형새
JPS5287221A (en)	1977-07-20	Preventive for chicken dinfections
SE8505558D0 (sv)	1985-11-25	Treklosslada for barn att rekna med procent
RO86744A2 (ro)	1985-04-17	Vaccin antisalmonelic aviar
NO891355D0 (no)	1989-03-30	Vaksinasjon mot rabis-beslektede virus.
IT8621418V0 (it)	1986-04-04	Dispositivo di ricircolo dell'acqua nei beverini per animali domestici.
ES263684Y (es)	1983-04-16	"jaula de pisos perfeccionada, para la cria y recria en avicultura".